Shiying Li
35PUBLICATIONS
7CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (35)
Sort by Publication Date:
|Mar 19, 2026
Chlorin e6 and Regorafenib Assemblies to Boost Photodynamic Immunotherapy through PD-L1 Downregulation and Tumor-Associated Macrophage Reprogramming.Chu-Yu Huang, Yun Ye, Shao-Yi Chen
|Mar 12, 2026
Stearic acid-modified PSMA-targeting peptide-drug conjugate for long-acting prostate cancer therapy.Ziwen Qiu, Xiaorui Zheng, Shoumei Pan
|Feb 17, 2026
Golgi Apparatus-Targeting Immunostimulant for Synergistic Activation of Antitumor Immunity via Pyroptosis Induction and PD-L1 Degradation.Rong-Rong Zheng, Qiu-Yuan Li, Shui-Ying Zhang
|Sep 25, 2025
Feedback-Amplified Drug Delivery of αPD-L1-Modified Lipoplatin for Chronological Synergy in NSCLC through PD-L1 Upregulation.Yi Cen, Xin-Xuan Li, Ying Chen
|May 05, 2025
Self-promoted tumor-targeting nanomedicine activates STING-driven antitumor immunity <i>via</i> photodynamic DNA damage and PARP inhibition.Baixue Yu, Wei Zhang, Zhouchuan Shao
|Jan 24, 2025
Chimeric Peptide Functionalized Immunostimulant to Orchestrate Photodynamic Immunotherapeutic Effect by PD-L1 Deglycosylation and CD47 Inhibition.Yi Cen, Xin-Xuan Li, Min Wang
Pageof 6
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [<sup>18</sup>F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=75)
